This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of John Dunlop
Introduction
John Dunlop, an inventive mind based in Allentown, NJ, has made significant strides in the field of pharmaceutical innovation. With a focus on developing inhibitors of glutamate transport, he holds a patent that underscores his contributions to science and medicine.
Latest Patents
John Dunlop is credited with a patent titled "Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport." This innovative work highlights his commitment to exploring new avenues for medical treatments and enhancing the understanding of biochemical pathways.
Career Highlights
Throughout his career, John Dunlop has worked at Wyeth, a well-known company in the pharmaceutical industry. His work there has allowed him to push the boundaries of research and development, focusing on creating therapeutic agents that have the potential to change lives.
Collaborations
John has collaborated with notable colleagues, including Gary Paul Stack and Alexander Greenfield. These partnerships have been instrumental in advancing their collective research efforts, fostering an environment of innovation and creativity in the workplace.
Conclusion
In conclusion, John Dunlop's contributions through his patent and collaborative work demonstrate his dedication to innovation in the pharmaceutical sector. His efforts at Wyeth and partnerships with fellow researchers point towards a promising future in the realm of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile